Apeloa Pharmaceutical Co Ltd
SZSE:000739
Intrinsic Value
Apeloa Pharmaceutical Co., Ltd. engages in research, development, and production of active pharmaceutical ingredient (API) intermediates, contract development and production services (CDMO), and prepa... [ Read More ]
The intrinsic value of one Apeloa Pharmaceutical Co Ltd stock under the Base Case scenario is 22.36 CNY. Compared to the current market price of 15.79 CNY, Apeloa Pharmaceutical Co Ltd is Undervalued by 29%.
Valuation Backtest
Apeloa Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling Apeloa Pharmaceutical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Apeloa Pharmaceutical Co Ltd
| Current Assets | 8.4B |
| Cash & Short-Term Investments | 2.5B |
| Receivables | 2.4B |
| Other Current Assets | 3.5B |
| Non-Current Assets | 4.4B |
| Long-Term Investments | 174m |
| PP&E | 3.6B |
| Intangibles | 340.1m |
| Other Non-Current Assets | 268m |
| Current Liabilities | 6.3B |
| Accounts Payable | 2B |
| Accrued Liabilities | 249.2m |
| Short-Term Debt | 3.4B |
| Other Current Liabilities | 691.8m |
| Non-Current Liabilities | 237.2m |
| Long-Term Debt | 23.2m |
| Other Non-Current Liabilities | 214m |
Earnings Waterfall
Apeloa Pharmaceutical Co Ltd
|
Revenue
|
11.6B
CNY
|
|
Cost of Revenue
|
-8.8B
CNY
|
|
Gross Profit
|
2.8B
CNY
|
|
Operating Expenses
|
-1.7B
CNY
|
|
Operating Income
|
1.1B
CNY
|
|
Other Expenses
|
-60.8m
CNY
|
|
Net Income
|
1.1B
CNY
|
Free Cash Flow Analysis
Apeloa Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Apeloa Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Apeloa Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Apeloa Pharmaceutical Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Apeloa Pharmaceutical Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Apeloa Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Apeloa Pharmaceutical Co Ltd is 21.17 CNY with a low forecast of 17.68 CNY and a high forecast of 25.2 CNY.
Shareholder Return
Price
Apeloa Pharmaceutical Co Ltd
| Average Annual Return | 30.67% |
| Standard Deviation of Annual Returns | 46.32% |
| Max Drawdown | -73% |
| Market Capitalization | 18.5B CNY |
| Shares Outstanding | 1 178 523 492 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Apeloa Pharmaceutical Co., Ltd. engages in research, development, and production of active pharmaceutical ingredient (API) intermediates, contract development and production services (CDMO), and preparations. The company is headquartered in Jinhua, Zhejiang and currently employs 6,133 full-time employees. The Company’s main products consist of bulk drugs, intermediates, chemical preparations, as well as Chinese traditional medicine preparations, such as ubenimex capsules, cefixime, amantadine and others. The firm distributes its businesses in domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Apeloa Pharmaceutical Co Ltd stock under the Base Case scenario is 22.36 CNY.
Compared to the current market price of 15.79 CNY, Apeloa Pharmaceutical Co Ltd is Undervalued by 29%.
You don't have any saved screeners yet
